Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-107,414
Closed -$12.8M 666
2025
Q1
$12.8M Buy
+107,414
New +$13.3M 0.32% 107
2023
Q3
Sell
-162,244
Closed -$18.3M 510
2023
Q2
$18.3M Buy
+162,244
New +$17.2M 0.66% 40
2022
Q4
Sell
-213,816
Closed -$18.7M 509
2022
Q3
$18.7M Buy
+213,816
New +$19.4M 0.89% 31
2017
Q2
Sell
-56,100
Closed -$2.82M 428
2017
Q1
$2.82M Buy
+56,100
New +$2.73M 0.14% 180

Other funds holding XYL

J. Goldman & Co's XYL Position: Q2 2025 in Review

J. Goldman & Co sold out of Xylem (XYL) in Q2 2025, closing a stake of 107,414 shares — an estimated $12.8M sold.

J. Goldman & Co first reported a position in XYL in Q1 2017 and held it in 4 quarters. The position peaked at $18.7M in Q3 2022. 1,063 funds tracked by Wall St. Rank hold XYL as of Q2 2025.

  • J. Goldman & Co reported no remaining Xylem position as of Q2 2025 after selling out during the quarter.
  • J. Goldman & Co sold 107,414 Xylem shares in Q2 2025, an estimated $12.8M.
  • J. Goldman & Co first reported a position in Xylem in Q1 2017 and held it in 4 quarters.
  • J. Goldman & Co's Xylem position peaked at $18.7M in Q3 2022.
  • 1,063 funds tracked by Wall St. Rank held Xylem as of Q2 2025.

Based on J. Goldman & Co's 13F filing for Q2 2025, filed 14 Aug 2025.